Market Analysis: US wellness economy surpasses $500B as GLP-1 drugs reshape chronic care spending
Type: Market Analysis · Industry: Salud y bienestar · Market: United States · Published: 2026-04-15
Executive Summary
The United States health and wellness industry has reached a pivotal inflection point, with the market surpassing $2.3 trillion in 2025 and projected to expand to $3.7 trillion by 2034 at a sustained 4–5% CAGR. The industry encompasses a broad spectrum of segments — from pharmaceuticals and digital health platforms to fitness, nutrition, and mental health services — each experiencing distinct but interconnected growth dynamics. The rise of GLP-1 receptor agonist drugs has emerged as the single most disruptive force in the sector, redistributing consumer and payer spending away from traditional chronic disease management toward integrated obesity-care ecosystems and companion wellness services.
Structural tailwinds are converging across regulatory, technological, and demographic dimensions. The CMS ACCESS Model, launching July 2026, will for the first time establish outcome-aligned reimbursement pathways for digital health interventions targeting hypertension, diabetes, and behavioral health — expanding the addressable market for digital wellness providers serving 40 million-plus Medicare beneficiaries. Simultaneously, the aging of the U.S. population, growing mental health awareness among Gen Z and Millennials, and employer-driven preventive care investments are generating durable demand across the value chain. Digital health venture funding reached $14.2 billion in 2025, with AI-enabled solutions capturing 62% of capital deployed.
Competitive dynamics are bifurcating between highly concentrated traditional healthcare incumbents and a fragmented but fast-growing cohort of wellness-first entrants. Market share shifts are accelerating as telehealth, direct-to-consumer supplement brands, and digital mental health platforms capture consumer spending that previously flowed through conventional healthcare channels. The industry's strategic outlook through 2030 is defined by GLP-1 companion services, digital reimbursement expansion, functional food innovation, and employer wellness ecosystems as the four highest-impact opportunity vectors for businesses operating in this space.
Key Findings
- The US wellness market reached $2.31 trillion in 2025 and is forecast to grow to $3.70 trillion by 2034, with GLP-1 drugs alone generating $76 billion in global sales in 2025 — projected to reach $162 billion by 2031 at a 17.5% CAGR.
- The CMS ACCESS Model launching July 5, 2026 establishes the first outcome-aligned reimbursement framework for technology-supported chronic care in Original Medicare, representing a structural catalyst for digital health monetization serving 40M+ beneficiaries.
- Group healthcare costs are projected to rise 8.5% in 2026, driven by GLP-1 drug utilization increases of 73.1% and specialty drug trend acceleration, creating simultaneous pressure on payers and strategic opportunity for cost-reduction-focused wellness platforms.
- Digital health venture funding surged to $14.2 billion in 2025 — the highest since 2022 — with AI-enabled startups capturing 62% of deployed capital and Q1 2026 already reaching $4 billion across 110 deals at an average deal size of $36.7 million.
- Functional foods and dietary supplements are forecast at 7.5–8.6% CAGR through 2030, with GLP-1 users projected to represent 35% of US food and beverage sales by 2030, reshaping product formulation priorities across the nutrition segment.
Report Contents
- 01 · Market Size
- 02 · Industry Segmentation
- 03 · Growth Drivers
- 04 · Competitive Landscape
- 05 · Value Chain
- 06 · Consumer Dynamics
- 07 · Distribution Channels
- 08 · Digital Maturity
- 09 · Regulatory Environment
- 10 · Investment Landscape
- 11 · Regional Analysis
- 12 · Innovation Ecosystem
- 13 · Industry SWOT
- 14 · Strategic Outlook
Related reports
- Audience Profiles: Gen Z mental health behavior and digital-first wellness preference reshaping consumer segments — Audience Profiles
- Competitive Benchmark: Retail pharmacy chains and major retailers pivoting to integrated wellness ecosystems — Competitive Benchmark
- Market Analysis: US behavioral health market expansion driven by employer mental health mandates in 2026 — Market Analysis
- Social Listening: Consumer advocacy discourse on healthcare cost transparency and affordability barriers — Social Listening
- Trend Analysis: Functional medicine and food-as-medicine movement reshaping preventive care in US — Trend Analysis
Access the full report
$29 USD/mo — Includes access to all reports for your industry.